As seen above, increasing although relatively sparse evidence suggests a role for G9a as a potential epigenetic molecular target in at least some types of adult and pediatric brain cancers, namely GBM and MB, in addition to NB, a neural tumor that can rarely occur intracranially. This evidence concerns the gene EHMT2 and neuroblastoma.